Actively Recruiting
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Led by Carevive Systems, Inc. · Updated on 2026-02-23
25
Participants Needed
7
Research Sites
180 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
CONDITIONS
Official Title
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All participants must be 18 years of age or older.
- Subjects may be any stage and anywhere in the treatment continuum.
- Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma.
- Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
- All participants must be able to understand English.
You will not qualify if you...
- Any patient who cannot understand written or spoken English.
- Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
- Any patient on a treatment clinical trial.
- Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Yale Cancer Center
New Haven, Connecticut, United States, 06511
Completed
2
Northshore University Health System
Evanston, Illinois, United States, 31024
Actively Recruiting
3
Univeristy of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599
Completed
4
Duke
Durham, North Carolina, United States, 27707
Completed
5
Cleveland Clinic Mercy Hospital
Canton, Ohio, United States, 44708
Actively Recruiting
6
University Hospitals Seidman Cancer Center
Cleveland, Ohio, United States, 44106
Actively Recruiting
7
Tri-County Hematology & Oncology Associates, Inc.
Massillon, Ohio, United States, 44646
Actively Recruiting
Research Team
J
JULIE SCOTT, MSN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here